iifl-logo-icon 1

Indraprastha Medical Corporation Ltd Share Price

456.15
(1.27%)
Sep 19, 2024|03:32:02 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open458
  • Day's High459.65
  • 52 Wk High484
  • Prev. Close450.45
  • Day's Low435.6
  • 52 Wk Low 149
  • Turnover (lac)1,657.35
  • P/E29.84
  • Face Value10
  • Book Value57
  • EPS15.08
  • Mkt. Cap (Cr.)4,181.53
  • Div. Yield1
View All Historical Data
No Records Found

Indraprastha Medical Corporation Ltd KEY RATIOS

Sector

Healthcare

Open

458

Prev. Close

450.45

Turnover(Lac.)

1,657.35

Day's High

459.65

Day's Low

435.6

52 Week's High

484

52 Week's Low

149

Book Value

57

Face Value

10

Mkt Cap (₹ Cr.)

4,181.53

P/E

29.84

EPS

15.08

Divi. Yield

1

Indraprastha Medical Corporation Ltd Corporate Action

17 May 2024

12:00 AM

Dividend

Dividend Amount: 4.5

arrow

7 Aug 2024

12:00 AM

BookCloser

arrow

4 Aug 2023

12:00 AM

AGM

Announcement Date: 04 Aug, 2023

arrow

24 Jul 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Indraprastha Medical Corporation Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Indraprastha Medical Corporation Ltd SHAREHOLDING SNAPSHOT

19 Sep, 2024|06:54 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 1.60%

Foreign: 1.60%

Indian: 49.39%

Non-Promoter- 4.84%

Institutions: 4.84%

Non-Institutions: 44.15%

Custodian: 0.00%

Share Price

Indraprastha Medical Corporation Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

91.67

91.67

91.67

91.67

Preference Capital

0

0

0

0

Reserves

386.09

287.78

233.77

181.08

Net Worth

477.76

379.45

325.44

272.75

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

613.38

830.76

748.35

765.71

yoy growth (%)

-26.16

11.01

-2.26

1.35

Raw materials

0

0

0

0

As % of sales

0

0

0

0

Employee costs

-197.71

-213.93

-194.01

-190.25

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

4.28

48.19

34

40.81

Depreciation

-33.32

-32.96

-30.68

-30.53

Tax paid

-1.96

-4.56

-12.9

-14.57

Working capital

22.2

-33.19

-0.47

28.16

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-26.16

11.01

-2.26

1.35

Op profit growth

-53.38

20

-8.64

-0.73

EBIT growth

-85.9

26.11

-11.94

5.52

Net profit growth

-94.66

106.71

-19.59

7.41

View Ratios

No Record Found

Indraprastha Medical Corporation Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

7,035.9

96.491,01,128.06251.70.231,936.6536.28

Max Healthcare Institute Ltd

MAXHEALTH

962.95

130.793,514.24154.140.16621.3979.01

Fortis Healthcare Ltd

FORTIS

592.95

338.8644,769.0226.830.17333.4120.36

Syngene International Ltd

SYNGENE

892.8

79.8235,922.473.90.14726.5104.14

Global Health Ltd

MEDANTA

1,114.8

80.6629,913.4996.280611.45106.08

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Indraprastha Medical Corporation Ltd

Management

Register Office

Registrar Office

Chairman & Non Executive Dir.

Jasmine Shah

Vice Chairman & Non executive

Prathap C Reddy

Non Executive Director

Suneeta Reddy

Non Executive Director

Sangita Reddy

Non Executive Director

Vineeta Rai

Independent Non Exe. Director

S Regunathan

Independent Non Exe. Director

Satnam Arora

Independent Non Exe. Director

Deepak Vaidya

Independent Non Exe. Director

Arun Rai

Independent Non Exe. Director

Vinayak Chatterjee

Independent Non Exe. Director

MADHUMITA GANGULI

Independent Non Exe. Director

Menaka Gurusswamy

Independent Non Exe. Director

Salil Singhal

Non Executive Director

Vikram Bhat

Non Executive Director

Mahesh Verma

Managing Director

P Shivakumar

Independent Director

Tejpreet S Chopra

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Reports by Indraprastha Medical Corporation Ltd

Summary

Indraprastha Medical Corporation was incorporated as Public Company on 16th March, 1988. The main business of the company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis.The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000. IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi. The hospital was originally planned to be located within the Indira Gandhi indoor stadium complex, Mahatma Gandhi Marg, New Delhi. In 1998-99, stroke unit to cater for strokes (Brain attack) with 4 beds has been established and a new OT complex consisting of 6 operation theatres has been commissioned. It has even set up a body mind medicine department based on ancient Eastern philosophy.During 1999-2000, the company signed a MOU with the Governments of Tanzania and Mauritius to treat patients from these countries sponsored by their Governments. It also has tie-ups with private air transport companies to transfer critical cases.A Puva UV therapy unit, for treatment of complex skin conditions, has been added in the dertamology department. The hospital has also installed an automated system in the microbiology unit for rapid cultures. A satellite clinic of the hospital, providing out door consultations and diagnostic facilities, was opened in Feb.2001, in Delhi. This clinic also functions as a referra
Read More

Company FAQs

What is the Indraprastha Medical Corporation Ltd share price today?

The Indraprastha Medical Corporation Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹456.15 today.

What is the Market Cap of Indraprastha Medical Corporation Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Indraprastha Medical Corporation Ltd is ₹4181.53 Cr. as of 19 Sep ‘24

What is the PE and PB ratio of Indraprastha Medical Corporation Ltd?

The PE and PB ratios of Indraprastha Medical Corporation Ltd is 29.84 and 8.63 as of 19 Sep ‘24

What is the 52 Week High and Low of Indraprastha Medical Corporation Ltd?

The 52-week high/low is the highest and lowest price at which a Indraprastha Medical Corporation Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Indraprastha Medical Corporation Ltd is ₹149 and ₹484 as of 19 Sep ‘24

What is the CAGR of Indraprastha Medical Corporation Ltd?

Indraprastha Medical Corporation Ltd's CAGR for 5 Years at 64.94%, 3 Years at 79.60%, 1 Year at 182.24%, 6 Month at 167.89%, 3 Month at 75.29% and 1 Month at 35.25%.

What is the shareholding pattern of Indraprastha Medical Corporation Ltd?

The shareholding pattern of Indraprastha Medical Corporation Ltd is as follows:
Promoters - 51.00 %
Institutions - 4.85 %
Public - 44.15 %

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Center

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
  • Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities / MF / Bonds in the consolidated account statement issued by NSDL/CDSL every month.
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp